首页|沉香倍半萜ZH-13保护内质网应激诱导神经元损伤作用机制

沉香倍半萜ZH-13保护内质网应激诱导神经元损伤作用机制

扫码查看
目的 基于沉香镇静安神的传统功效,探讨其活性成分倍半萜ZH-13对内质网应激诱导神经元损伤的改善作用及作用机制.方法 采用内质网应激诱导剂衣霉素(tunicamycin,Tm)诱导大鼠肾上腺嗜铬细胞瘤PC12细胞内质网应激,检测倍半萜ZH-13对细胞存活率、细胞凋亡及内质网应激相关蛋白表达的影响.结果 Tm以剂量相关性降低PC12细胞的存活率(P<0.01),ZH-13显著提高Tm损伤PC12细胞的存活率(P<0.01)并改善内质网应激.通过对蛋白激酶样内质网激酶(protein kinase RNA-like endoplasmic reticulum kinase,PERK)、肌醇需求酶 1(inositol-requiring enzyme 1,IRE1)、转录活化因子6(activating transcription factor 6,ATF6)3条通路相关蛋白的分析,证实ZH-13显著抑制内质网应激PERK通路的过度激活(P<0.05),而对IRE1、ATF6通路的作用不明显.结论 ZH-13通过调控PERK通路改善内质网应激介导的PC12细胞损伤,显示出良好的神经保护作用.
Mechanism of Aquilariae Lignum Resinatum sesquiterpene ZH-13 in protecting neuronal injury induced by endoplasmic reticulum stress
Objective To explore the improvement effect and mechanism of action of the active component sesquiterpene ZH-13 on endoplasmic reticulum(ER)stress-induced neuronal injury based on the traditional sedative effect of Chenxiang(Aquilariae Lignum Resinatum).Methods The ER stress inducer tunicamycin(Tm)was used to trigger ER stress in PC12 cells,and the effects of ZH-13 on cell viability,apoptosis,and expression of ER stress-related proteins were examined.Results The results showed that Tm reduced PC12 cell in a dose-dependent manner(P<0.01),and ZH-13 significantly increased cell viability(P<0.01)and ameliorated ER stress.By analyzing the proteins related to protein kinase RNA-like endoplasmic reticulum kinase(PERK),inositol-requiring enzyme 1(IRE1),and activating transcription factor 6(ATF6),it was confirmed that ZH-13 significantly inhibited the overactivation of the PERK pathway in ER stress(P<0.05),with no obvious effect on the IRE1 and ATF6 pathways.Conclusion ZH-13 improves ER stress-mediated damage in PC12 cells by regulating the PERK pathway,demonstrating a good neuroprotective effect.

Aquilariae Lignum Resinatumsesquiterpene ZH-13endoplasmic reticulum stressIRE1 pathwayATF6 pathwayPERK pathway

高云、薛伟刚、王俊娇、马家乐、黄杨丽、赵茂源、张瑞杰、郑得丽、阴紫钰、赵云芳、郑姣、李军

展开 >

北京中医药大学中医药研究院中药现代研究中心,北京 102488

北京中医药大学中药学院,北京 102488

沉香 倍半萜ZH-13 内质网应激 IRE1通路 ATF6通路 PERK通路

2025

中草药
天津药物研究院,中国药学会

中草药

北大核心
影响因子:1.632
ISSN:0253-2670
年,卷(期):2025.56(2)